Dialectic Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3889 Maple Ave Ste 125, Dallas, Texas, 7...Phone Number
(972) 525-1499Website
www.dtsciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Dialectic Therapeutics
Dialectic Therapeutics is a biotechnology company focused on developing innovative anti-cancer drugs, particularly targeting patients with limited treatment options. Their lead product, DT2216, is designed to induce cancer cell death by degrading the BCL-XL protein, and is currently in clinical trials for various cancers. The company aims to provide hope and improve the quality of life for cancer patients through targeted therapies with minimal side effects. Based in Dallas, Texas, Dialectic collaborates with leading research institutions to advance its therapeutic candidates.Explore more
Dialectic Therapeutics Org Chart
JS
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dialectic Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Dialectic Therapeutics has new funding data
Dialectic Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Dialectic Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Dialectic Therapeutics
Check out if Dialectic Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Dialectic Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Dialectic Therapeutics recently announced quarterly report
Check if Dialectic Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Dialectic Therapeutics
Compare insights from companies similar to Dialectic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Dialectic Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dialectic Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dialectic Therapeutics.
Dialectic Therapeutics Tech Stack
A closer look at the technologies used by Dialectic Therapeutics
See more technologies
Dialectic Therapeutics News & Media
The Fibrolamellar Cancer Foundation establishes partnership with Dialectic Therapeutics
Effort will support a new clinical trial for fibrolamellar carcinoma, a rare cancer that primarily impacts children and young adults GREENWICH, CT, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- The Fibrolamellar Cancer Foundation (FCF) is pleased …Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma
DALLAS, March 14, 2022 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug...Dialectic Therapeutics Receives $14.4 Million Texas Company Product Development Research Award from the Cancer Prevention & Research Institute of Texas
DALLAS, Aug. 20, 2021 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic®), a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer, today announced it has received a $14.4 million Texas Company (TXCO) Product Development...Dialectic Therapeutics Receives FDA Clearance of IND Application for Lead Antiapoptotic Protein Targeted Degradation (APTaD) Candidate DT2216
DALLAS, March 3, 2021 /PRNewswire/ -- Dialectic Therapeutics, Inc. (Dialectic®), a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, today announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Dialectic Therapeutics
Sign Up For FreeTo access detailed company insights
Dialectic Therapeutics is a biotechnology company focused on developing innovative anti-cancer drugs, particularly targeting patients with limited treatment options. Their lead product, DT2216, is designed to induce cancer cell death by degrading the BCL-XL protein, and is currently in clinical trials for various cancers. The company aims to provid... Read More
